Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply

Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbekistan a key hub for making and supplying medicines in the region. Simplified rules and tax benefits will encourage more investment. This move will boost local healthcare and strengthen trade ties between the two nations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hzZ18xB
via IFTTT

Read More

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoarthritis pain in adults with obesity. Patients also experienced substantial weight loss. These findings were shared at an American Diabetes Association conference. Retatrutide targets multiple hormones related to obesity and diabetes.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iIhEzGt
via IFTTT

Read More

Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak Securities

Indian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expected to remain stable. This outlook comes despite significant bed expansion. Hospital volumes and diagnostics are showing positive trends. The March quarter performance was robust, with sales and EBITDA growth reported. This indicates a healthy sector outlook for the coming period.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JCirLdg
via IFTTT

Read More

Regulator, cos discuss price hike for some cancer drugs

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin and cisplatin, are crucial for treating various cancers. The National Pharmaceutical Pricing Authority met with drug makers and hospital representatives to discuss the issue. Rising raw material costs have put pressure on production.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ebQqRAr
via IFTTT

Read More

Manipal Health takes Bengaluru hospital building on long-term lease

Manipal Health Enterprises has leased a 245,000-sq ft multi-speciality hospital in Bengaluru's Yelahanka for nearly 30 years, with an estimated total rental outgo of ₹816.1 crore. The lease agreement includes a starting monthly rent of ₹1.27 crore and a 10% rent escalation in the sixth year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PG2n5xB
via IFTTT

Read More

PE wars to billion-dollar IPO dreams, hospital sector is fighting fit

Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in specialized medical services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S3xQGYv
via IFTTT

Read More

Warburg, KKR, TPG among PE giants vying for 25% stake in Cloudnine

Global private equity giants, including Warburg Pincus and KKR, are vying for a 25% stake in India's largest maternity and pediatric hospital chain, Cloudnine. The deal is expected to value the company at approximately $1 billion, with existing investor True North exiting completely. Cloudnine reported revenues of ₹2,000 crore and EBITDA of ₹300 crore in FY26.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KIsAC3d
via IFTTT

Read More